| Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III … DJ Slamon, P Neven, S Chia, G Jerusalem, M De Laurentiis, S Im, ... Annals of oncology 32 (8), 1015-1024, 2021 | 259 | 2021 |
| Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced … YS Lu, SA Im, M Colleoni, F Franke, A Bardia, F Cardoso, N Harbeck, ... Clinical Cancer Research 28 (5), 851-859, 2022 | 201 | 2022 |
| Updated overall survival (OS) results from the phase III MONALEESA-3 trial of postmenopausal patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with fulvestrant … DJ Slamon, P Neven, SKL Chia, GHM Jerusalem, M De Laurentiis, SA Im, ... J Clin Oncol 39 (15_suppl), 1001-1001, 2021 | 82 | 2021 |
| Epidemic cystic and alveolar echinococcosis in Kyrgyzstan: an analysis of national surveillance data G Paternoster, G Boo, C Wang, G Minbaeva, J Usubalieva, KM Raimkulov, ... The Lancet Global Health 8 (4), e603-e611, 2020 | 76 | 2020 |
| Modelling anthelmintic resistance by extending eggCounts package to allow individual efficacy C Wang, PR Torgerson, RM Kaplan, MM George, R Furrer International Journal for Parasitology: Drugs and Drug Resistance 8 (3), 386-393, 2018 | 74 | 2018 |
| Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre-or perimenopausal patients with hormone receptor positive/human epidermal … D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, S Hurvitz, ... Cancer research 81 (4_Supplement), PD2-04-PD2-04, 2021 | 48 | 2021 |
| Zero-inflated hierarchical models for faecal egg counts to assess anthelmintic efficacy C Wang, PR Torgerson, J Höglund, R Furrer Veterinary parasitology 235, 20-28, 2017 | 44 | 2017 |
| Generalized spatial fusion model framework for joint analysis of point and areal data C Wang, MA Puhan, R Furrer, SNC Study Group Spatial Statistics 23, 72-90, 2018 | 28 | 2018 |
| LBA4 Updated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2− advanced … P Neven, PA Fasching, S Chia, G Jerusalem, M De Laurentiis, SA Im, ... Annals of Oncology 33, S194, 2022 | 18 | 2022 |
| Local-likelihood transformation kernel density estimation for positive random variables G Geenens, C Wang Journal of Computational and Graphical Statistics 27 (4), 822-835, 2018 | 15 | 2018 |
| Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis B Holzhauer, C Wang, H Schmidli Statistics in medicine 37 (6), 867-882, 2018 | 12 | 2018 |
| eggCounts: Hierarchical Modelling of Faecal Egg Counts C Wang, M Paul, R Furrer R package version 2.0, 2018 | 12* | 2018 |
| Sensitivity analyses for the principal ignorability assumption using multiple imputation C Wang, Y Zhang, F Mealli, B Bornkamp Pharmaceutical Statistics, 2022 | 9 | 2022 |
| Combining heterogeneous spatial datasets with process-based spatial fusion models: A unifying framework C Wang, R Furrer, SNC Study Group Computational Statistics & Data Analysis 161, 107240, 2021 | 8 | 2021 |
| Call completion probability in heterogeneous networks with energy harvesting base stations C Wang, S Durrani, J Guo, X Zhou 2015 22nd International Conference on Telecommunications (ICT), 191-197, 2015 | 8 | 2015 |
| Increase in airway obstruction between 1993 and 2012 in Switzerland. An observational study EA West, A Strassmann, C Wang, A Turk, K de Hoogh, M Röösli, M Bopp, ... Annals of the American Thoracic Society 17 (4), 457-465, 2020 | 7 | 2020 |
| Methodology for good machine learning with multi‐omics data T Coroller, B Sahiner, A Amatya, A Gossmann, K Karagiannis, C Moloney, ... Clinical Pharmacology & Therapeutics 115 (4), 745-757, 2024 | 6 | 2024 |
| eggCounts: a Bayesian hierarchical toolkit to model faecal egg count reductions C Wang, R Furrer arXiv preprint arXiv:1804.11224, 2018 | 5 | 2018 |
| Efficient inference of generalized spatial fusion models with flexible specification C Wang, R Furrer Stat 8 (1), e216, 2019 | 4 | 2019 |
| Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation … P Konstantinopoulos, JW Kim, G Freyer, JY Lee, L Gaba, R Grisham, ... Gynecologic Oncology 190, S12, 2024 | 3 | 2024 |
Reinhard FurrerProfessor of Applied Statistics, University of ZurichVerifisert e-postadresse på math.uzh.ch